Ticagrelor Improves Peripheral Arterial Function in Acute Coronary Syndrome Patients: Relationship With Adenosine Plasma Level.
Julien
J
Fromonot
Françoise
F
Dignat-Georges
Pascal
P
Rossi
Giovanna
G
Mottola
Nathalie
N
Kipson
Jean
J
Ruf
Laurent
L
Bonello
Régis
R
Guieu
Franck
F
Paganelli
D054058:Acute Coronary Syndrome / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D000241:Adenosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood*; D000368:Aged; D001158:Arteries / Q000187:drug effects*; D001241:Aspirin / Q000008:administration & dosage; D015415:Biomarkers / Q000097:blood; D000077144:Clopidogrel; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005121:Extremities / Q000098:blood supply; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D058729:Peripheral Arterial Disease / Q000188:drug therapy* / Q000517:prevention & control; D011446:Prospective Studies; D012720:Severity of Illness Index; D015996:Survival Rate; D000077486:Ticagrelor; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome
D015415:Biomarkers; D000077144:Clopidogrel; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine; D001241:Aspirin